InnovaCare is the leading Medicare and Medicaid firm that offers healthcare related services in Puerto Rico. It is the amazing leadership skills that has made the company an exceptional investment in the nation. Among the many personnel in the company, Penelope Kokkinides is one individual that you will be pleased to know or meet up. Penelope has contributed immensely to the growth of InnovaCare.
InnovaCare Inc. offers health services in Puerto Rico. It also manages two other government Medicaid plans in the nation and has benefited many citizens through a structured health care model. The company is also dedicated to offering the nation with accredited health plans and top-notch healthcare services by creating sustainable models of monitored care. Its services are also cost effective, innovative and based on an integrated technology.
Penelope Kokkinides has brought vast changes into the company that has not only benefited Puerto Rico but also the United States. She was invited to the Whitehouse alongside seven other women by President Donald Trump to discuss health affairs in the nation and world in general. During the meeting, Ms. Penelope mentioned the importance of Medicare fund increment.
Penelope clarified that the cut in the funding will led to the collapse of the Medicaid system in Puerto Rico. Penelope said that such decision will push many people to migrate from the Puerto Rico to USA where Medicaid cost is higher three to four times. After the meeting, President Donald trump released a notice that brought a lot of changes to Puerto Rico’s healthcare systems.
What to Know About Penelope Kokkinides
Penelope Kokkinides is the Chief Administrative officer at InnovaCare, Inc. since 2015. She served as the Chief operating officer in the same organization and as the vice president of clinical operations. She has been operating in the healthcare sector for more than 20 years specializing in government programs such as Medicaid and Medicare. Before joining InnovaCare Inc. she worked as the executive vice president and chief operating officer at Centerlight HealthCare.
Penelope Kokkinides is a bachelor’s degree holder in biological sciences and classical languages from the reputed University of Binghamton. She also holds a master’s degree in social work from New York University. Ms. Kokkinides is also a post-master’s program specialist with an advanced degree in alcohol and substance abuse as well as a master’s degree in public health from Columbia University School of Public Health.
Rich Shinto; the President and CEO at InnovaCare Health, brings technical and leadership experience from the service in clinical and operational healthcare. According to him, InnovaCare emphasizes qualified professionals to ensure stability and spearhead the growth of the company. He adds that teamwork is another value that enhances the company’s success. The ingredients that lead to success include good working relationships, proper communication, and a clear vision. Read more about Rick on Businesswire.
Dr. Shinto’s Career Development
As a team leader, Shinto was awarded the Young & Ernst Entrepreneur of the year that recognizes individuals who are dedicated to excellence. Shinto began his career as an intern in Southern California where he served as a pulmonologist, and he later served as Vice President of Medical Management. He also joined Cal Optima Health Plan in Orange County and served as the Chief Medical Officer. Previously, Shinto was the Chief Operating and Medical Officer of Medical Pathways Management Company. He has an experience of more than 20 years in the medical care field.
Contribution to InnovaCare Health
Dr. Rick Shinto has brought active leadership transformation to InnovaCare Health, and he was recently joined by three other professionals to enhance the success of the company. According to him, InnovaCare is likely to expand into other markets where it can make improvements that will benefit the patients. Immediately after he was hired the Chief Executive Officer, Dr. Shinto proved himself as the leader who inspires other employees to work diligently and successfully.
Under the leadership of Dr. Shinto, InnovaCare Health has attracted huge following where visits to the doctor’s office have become more cost-effective to the average person. Nowadays, more Puerto Rican residents can access better healthcare because of the wise use of technology that enables the company to provide cheap options while maintaining the quality of its services. As a result, more than 70 percent of the residents have chosen InnovaCare instead of other insurance firms.
InnovaCare Health has two affiliates in Puerto; PMC Medicare Choice Inc. and MMM Healthcare Inc. that provide high-quality health care plans. These plans promote the emotional and physical wellbeing of the company’s members. The success of the two affiliates has led to the rise in customer satisfaction to 90 percent. In 2011, both PMC and MMM received NCQA accreditation that is only presented when a program meets or exceeds the expectations of quality assurance. The determinants of this accreditation are the quality improvement and client protection.
Mindstrong Health is a platform that has recently transformed diagnosing and delivering precision therapy. The founding team of Mindstrong Health brings to our knowledge the vital challenges faced by the medical community in delivering care to patients suffering from cognitive health disorder. One of the lead investors of the company is Jim Tananbaum, the CEO and Managing Director of Foresite Capital, who praised the platform for its outstanding services. This is because of the quality care the platform offers to individuals. Mindstrong is an Al-powered platform designed to specifically monitor the patterns of an individual on his/her smart-phone devices in order to measure the brain function. The objective of the platform is to offer a transformative biotechnology in healthcare services. Therefore, the company developed a biomarker panel which includes attention, memory processing speed and executive function.
About Mindstrong Health
The company came up with an outstanding way of keeping track of mental health. This has been a challenging part for the medical community. With Mindstrong’s Technology, it has made it possible to deliver continuous and systematic measurement of behavior and cognition at a precise level of insight and resolution. This remains as a major breakthrough in the medical sector. Previously all modern medicine depended on an objective measurement while Mindstrong depends on keeping a real time data by tracking mental health.
Foresite Capital and ARCH Venture Partners led the round through investing and campaigning for the remarkable platform, and were later joined by Optum Ventures, Berggruen Holdings and the One Mind Brain Health Impact Fund.
About Jim Tananbaum
Besides Jim Tananbaum being the founding CEO of Foresite Capital Management with $1.1 billion in assets management, he has also led investments in 21 successful health companies. According to Inc42, this includes Amira Pharmaceuticals which was later on acquired by Bristol-Myers Squibb, Amerigroup and Pharmaceuticals. Jim had previously founded and held management positions at GelTex Pharmaceuticals which was acquired by Genzyme for $1.6 Billion. Dr. Tananbaum has more than 20 years of experience in building and investing in healthcare companies. Jim Tananbaum is one of the most relevant professionals in the world medical community. This is evident with his level of education. He holds an M.D. from Harvard Medical School, an M.B.A from Harvard Business School, and also attained a B.S. and B.S.E.E from Yale University. He surely is one of the leading figures in the medical community. Read ideamensch’s interview of Mr. Tananbaum here.
The possibility of immunity enhancement in humans as shown by 2014 studies caused a celebration in the science world as this was considered a breakthrough in the research on human immortality. This was the turning point that was made as a prediction back in the days about ten years ago. The cause of human death especially when aging is eliminated.
The belief that aging was as a result of the functional decline in the accumulation of random molecular damage stood the test of time until recently. This belief has only been broken because of the theory that explains aging as a growth continuation process that signals unique pathways including TOR. This centric model makes the prediction of how rapamycin can be effectively used in the treatment of aging and preventing diseases. This way people get to grow older and healthier thus prolonging lives and delaying death. Research has shown that Rapamycin and other related drugs can help extend human life as long as they are administered in appropriate dosages as well as schedules. Visit ResearchGate to keep up to date with Mikhail’s latest work.
Mikhail Blagosklonny is known to have made major contributions towards the development of cancer treatment as well as participated in the advancement of anti-aging solutions. Being a professor of Oncology, Mikhail explains the phenomenon surrounding aging as he is well known for conducting significant studies around this subject and cancer cures. Mikhail is a Professor at the Roswell Cancer Center. He attended the Pavlov State Medical University of St Petersburg where he attained an MD in Internal Medicine. He also earned his Ph.D. in Experimental Medicine. He served as a senior scientist at Ordway research institute. Mikhail became great at research work due to the experience he continually gained at the different places he worked.
Mikhail also works as the Chief Editor of Oncotarget as well as the Cell Cycle. Additionally, he serves as an associate editor for the Cancer and Biology Therapy. He also serves on Cell Division and Differentiation board of editors. He developed a hypothesis based on TOR signaling as he researched on its role for cancer treatment and in aid of anti-aging process. He is the one who made the proposal on the use of Rapamycin, which is a popular drug in the treatment of cancer as well as in the longevity research.
Professor Mikhail handles research that ranges from molecular biology, cellular biology as well as clinical investigations. This includes mainly focus on areas such as ontogenesis, apoptosis, anti-cancer therapeutics, mitosis, tumor suppressors as well as signal transduction. Mikhail has authored the hyperactive function theory. He has also been instrumental in the writing of chemotherapeutic engineering as well as the cell cyclotherapy.
Dr. Mikhail Blaglosklonny has a strong belief that cancer and aging are matters that can be controlled. He also believes in the cure of cancer, which explains his proposal of rapamycin as a potential treatment, and people do not have to die because of something that can be controlled. It is these research findings that have helped propel him to succeed in his career. View Mikhail’s profile on Google Scholar